Forbes: Approval of Use of New Embryonic Stem Cell Lines Promotes Outdated Science
December 02, 2009
December 02, 2009
WASHINGTON, Dec. 2 -- Rep. J. Randy Forbes, R-Va. (4th CD), issued the following news release:
In light of the Administration's approval today of new human embryonic stem cell lines for federally funded experiments, Congressman J. Randy Forbes (VA-04) called on Congress to consider his Patients First Act, H.R. 877 (http://thomas.loc.gov/cgi-bin/bdquery/z?d111:h.r.877:). Forbes' bipartisan bill would intensify research and human clinical trials using stem cells that are ethically o . . .
In light of the Administration's approval today of new human embryonic stem cell lines for federally funded experiments, Congressman J. Randy Forbes (VA-04) called on Congress to consider his Patients First Act, H.R. 877 (http://thomas.loc.gov/cgi-bin/bdquery/z?d111:h.r.877:). Forbes' bipartisan bill would intensify research and human clinical trials using stem cells that are ethically o . . .